SILVER SPRING, MD – Shares of United Therapeutics Corporation (NASDAQ: UTHR) experienced a dramatic sell-off in recent trading, wiping out a significant portion of its market value in a single day. The stock closed at $278.20, a staggering drop of $50.20, which represents a -15.29% decline.
The UTHR chart shows a catastrophic open for the stock, gapping down significantly from its previous close of $328.40. After the initial plunge, the stock traded sideways at its new, much lower level, indicating a market shock likely triggered by a major negative catalyst such as disappointing clinical trial data or a regulatory setback.
This precipitous one-day drop has severely impacted the stock’s performance across multiple timeframes:
-
5 days: -14.13%
-
1 month: -9.46%
-
6 months: -22.91%
-
Year to date: -20.79%
Despite the brutal session, the long-term picture for United Therapeutics offers some perspective. The stock is still slightly positive over a one-year period with a 2.12% gain and boasts an impressive five-year return of 124.81%. This suggests a history of strong performance prior to this recent and significant setback. Investors will now be keenly focused on the specific news that prompted the sell-off and the company’s strategy moving forward.
Frequently Asked Questions (FAQ) about United Therapeutics (UTHR) Stock
Here are answers to the most common questions about UTHR’s stock based on the provided information.
1. What is the current stock price of United Therapeutics Corporation?
As of the last report, the stock price for United Therapeutics (UTHR) is $278.20 USD.
2. What is the stock ticker for United Therapeutics?
The company’s official stock ticker symbol is UTHR.
3. On which stock exchange is UTHR traded?
UTHR is listed and traded on the Nasdaq Stock Market.
4. How did UTHR stock perform today?
The stock had a very poor session, dropping by $50.20, which is a decline of -15.29%.
5. What was the previous closing price for UTHR?
The previous day’s closing price for the stock was $328.40.
6. What does the intraday stock chart for UTHR show?
The chart shows a massive “gap down,” where the stock opened for trading significantly lower than its previous close. This typically indicates that major negative news was released after the market closed the previous day or before it opened today.
7. How has the recent sell-off impacted the stock’s performance?
The single-day drop has pushed the stock’s performance into negative territory over the last 5 days (-14.13%), 1 month (-9.46%), 6 months (-22.91%), and for the year to date (-20.79%).
8. What is the one-year performance of UTHR stock?
Despite the recent drop, the stock is still up 2.12% over the past 12 months.
9. How has the stock performed over the long term (5 years)?
Over the last five years, UTHR stock has provided investors with a strong return of 124.81%.
10. What is the all-time performance of UTHR stock?
Since its initial public offering, UTHR has delivered an exceptional all-time gain of 4.03K%, which is 4,030%.
11. What does United Therapeutics Corporation do?
United Therapeutics is a biotechnology company focused on the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening conditions. The logo, featuring lungs inside a heart, suggests a focus on cardiopulmonary diseases.
